References

Can cisplatin therapy be improved? pathways that can be targeted

10.3390/ijms23137241 · 2022 · External reference

Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response

10.1093/neuonc/noaa151 · 2021 · External reference

Sirt2 protects peripheral neurons from cisplatin-induced injury by enhancing nucleotide excision repair

10.1172/jci123159 · 2020 · External reference

Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy

10.1200/jco.2016.71.3552 · 2017 · External reference

Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment

10.1111/jns.12335 · 2019 · External reference

Corneal nerve changes following treatment with neurotoxic anticancer drugs

10.1016/j.jtos.2021.06.007 · 2021 · External reference

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update

10.1200/jco.20.01399 · 2020 · External reference

Recent advances in small molecule nav 1.7 inhibitors for cancer pain management

10.1016/j.bioorg.2024.107605 · 2024 · External reference

Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents

10.1016/j.fct.2019.111079 · 2020 · External reference

Insights into platinum-induced peripheral neuropathy-current perspective

10.4103/1673-5374.276321 · 2020 · External reference

Current understanding of membrane transporters as regulators or targets for cisplatin-induced hearing loss

10.1124/molpharm.121.000274 · 2021 · External reference

Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

10.3390/cancers12092605 · 2020 · External reference

Dynamic and cell specific transport networks for intracellular copper ions

10.1242/jcs.240523 · 2021 · External reference

Interference between copper transport systems and platinum drugs

10.1016/j.semcancer.2021.05.023 · 2021 · External reference

Drug resistance in ovarian cancer: from mechanism to clinical trial

10.1186/s12943-024-01967-3 · 2024 · External reference

Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions

10.1002/jcsm.12208 · 2017 · External reference

Benefits of beta-hydroxy-beta-methylbutyrate supplementation in trained and untrained individuals

10.1080/15438627.2018.1533470 · 2019 · External reference

Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research

10.1002/jcsm.12954 · 2022 · External reference

The effects of beta-hydroxy-beta-methylbutyrate or HMB-rich nutritional supplements on sarcopenia patients: a systematic review and meta-analysis

10.3389/fmed.2024.1348212 · 2024 · External reference

Beta-hydroxy-beta-methylbutyrate ameliorates aging effects in the dendritic tree of pyramidal neurons in the medial prefrontal cortex of both male and female rats

10.1016/j.neurobiolaging.2016.01.004 · 2016 · External reference

Effects of beta-hydroxy-beta-methyl butyrate on working memory and cognitive flexibility in an animal model of aging

10.1080/1028415x.2016.1145376 · 2017 · External reference

Sesamol epigenetically induces estrogen receptor alpha re-expression by upregulating miR-370-3p in estrogen receptor alpha-negative breast cancer

10.1021/acs.jafc.1c03159 · 2021 · External reference

Assessment of the anti-allodynic and anti-hyperalgesic efficacy of a glycine transporter 2 inhibitor relative to pregabalin, duloxetine and indomethacin in a rat model of cisplatin-induced peripheral neuropathy

10.3390/biom11070940 · 2021 · External reference

Dose translation between laboratory animals and human in preclinical and clinical phases of drug development

10.1002/ddr.21461 · 2018 · External reference

Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via SPRY4 upregulation-mediated ERK1/2 signaling inhibition

10.1016/j.bcp.2024.116414 · 2024 · External reference

Advances in toxicological research of the anticancer drug cisplatin

10.1021/acs.chemrestox.9b00204 · 2019 · External reference

Thymoquinone prevents cisplatin neurotoxicity in primary DRG neurons

10.1016/j.neuro.2018.09.001 · 2018 · External reference

The drug-resistance mechanisms of five platinum-based antitumor agents

10.3389/fphar.2020.00343 · 2020 · External reference

Role of ubiquitination in the occurrence and development of osteoporosis (review)

10.3892/ijmm.2024.5392 · 2024 · External reference

Copper promotes tumorigenesis by activating the PDK1-AKT oncogenic pathway in a copper transporter 1 dependent manner

10.1002/advs.202004303 · 2021 · External reference

Mechanism of action and the effect of beta-hydroxy-beta-methylbutyrate (HMB) supplementation on different types of physical performance-a systematic review

10.2478/hukin-2019-0070 · 2019 · External reference

Effects of β-hydroxy β-methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review

10.1002/jcsm.12952 · 2022 · External reference

International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB)

10.1080/15502783.2024.2434734 · 2025 · External reference

Modulating metabolism to improve cancer-induced muscle wasting

10.1155/2018/7153610 · 2018 · External reference

Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers

10.1097/j.pain.0000000000001667 · 2019 · External reference

Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review

10.1093/bja/aex229 · 2017 · External reference

Recommendations for prevention and management of chemotherapy-induced peripheral neuropathy

10.1001/jama.2021.7458 · 2021 · External reference

Comparison of the anticatabolic effects of leucine and Ca-beta-hydroxy-beta-methylbutyrate in experimental models of cancer cachexia

10.1016/j.nut.2013.11.012 · 2014 · External reference

Transport mechanisms for the nutritional supplement beta-hydroxy-beta-methylbutyrate (HMB) in mammalian cells

10.1007/s11095-019-2626-3 · 2019 · External reference

Dietary approaches for controlling cancer by limiting the Warburg effect: a review

10.1093/nutrit/nuad130 · 2024 · External reference

Novel nonsymmetrical 1,4-dihydropyridines as inhibitors of nonsymmetrical MRP-efflux pumps for anticancer therapy

10.3390/ph13070146 · 2020 · External reference